medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2012, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2012; 28 (2)

Risks of ischemic stroke in children suffering Sβ-thalassemia. Transcranial Doppler study

Scherle-Matamoros CE, Fernández-Cue L, Alvarado-Henríquez JD, Svarch E, González-Otero A

Language: Spanish
References: 18
Page: 169-176
PDF size: 88.81 Kb.


ABSTRACT

In children with sickle cell anemia, the risk of ischemic stroke varies according to genotype of hemoglobinopathy. In these cases, determining the velocity of blood flow by transcranial Doppler (TCD) can predict the occurrence of cerebral ischemia. In order to describe the characteristics of DTC in Sβ thalassemia, we studied 32 patients younger than 18 treated at the Institute of Hematology and Immunology, who were referred for ultrasound assessment. The age rate of children was 10.5 years old. We studied the same number of patients with each genotype Sβ, in only one patient the time window was not useful. 97 % of patients the mean flow velocity in the middle cerebral arteries was less than 170 cm/s and only one child was in the range of conditional group. Interhemispheric asymmetries were registered in the average flow rate of the anterior cerebral arteries in 29 % cases, 19.6 % registered it in the middle cerebral arteries, and 6.4 % in the extracranial internal carotid. The highest levels of average flow rate were registered in patients with thalassemia Sβ0 and middle cerebral arteries. There was an inverse correlation between age and hemoglobin levels with the flow rate of three studied vessels. The risk of ischemic stroke in the Sβ thalassemia is low, with no difference between the two assessed genotypes.


REFERENCES

  1. Earley CJ, Kittner SJ, Feeser BR, Gardner J, Epstein A, Wozniak MA, et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998;51(1):169-76.

  2. Ohene-Frempong K, Wiener SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-94.

  3. Francis RB, Johnson CS. Vascular occlusion in sickle cell disease: Current concepts and unanswered questions. Blood. 1991;77(7):1405-14.

  4. Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, Wang WC, et al. The spectrum of brain MR abnormalities in sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. Am J Neuroradiol. 1996;17(5):965-72.

  5. Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, et al. Assessment: transcranial Doppler ultrasonography. Report of the therapeutics and technology assessment Subcommittee of the American Academy of Neurology. Neurology. 2004;62(9):1468-81.

  6. Suliman H, Wali Y, Al Saadoon M, Zechariah M, William RR, Gujjar A, et al. Hydroxyurea or chronic exchange transfusions in patients with sickle cell disease. Role of transcranial Doppler ultrasound in stroke prophylaxis. J Pediatr Hematol Oncol. 2009;31(1):42-4.

  7. Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K, et al. The use of transcraneal ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326(9):605-10.

  8. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusion in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New Engl J Med. 1998;339(1):5-11.

  9. Adams RJ. Big strokes in small persons. Arch Neurol. 2007;64(11):1567-74.

  10. Thein SL. Genetic modifiers of the β-haemoglobinopathies. Br J Haematol. 2008;141(3):357-66.

  11. González-Redondo JM, Kutlar F, Kutlar A, Stoming TA, de Pablos JM, Kilinç Y, et al. Hb S(C)- β+-thalassaemia: different mutations are associated with different levels of normal Hb A. Br J Haematol. 1988;70(1):85-9.

  12. Bulas D. Screening children for sickle cell vasculopathy: guidelines for transcraneal Doppler evaluation. Pediatr Radiol. 2005;35(3):235-41.

  13. Manfrè L, Giarratano E, Maggio A, Banco A, Vaccaro G, Lagalla R. MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cellthalassemia disease. Am J Roentgenol. 1999;173(6):1477-80.

  14. Kirkham FJ, Hewes DK, Prengler M, Wade A, Lane R, Evans JP. Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet. 2001;357(9269):1656-59.

  15. Zafeiriou DI, Prengler M, Gombakis N, Kouskouras K, Economou M, Kardoulas A, et al. Central nervous system abnormalities in asymptomatic young patients with Sβ thalassemia. Ann Neurol. 2004;55(6):835-39.

  16. Schmidt EA, Piechnik SK, Smielewski P, Raabe A, Matta BF, Czosnyka M. Symmetry of cerebral hemodynamic indices derived from bilateral transcranial Doppler. J Neuroimaging. 2003;13(3):248-54.

  17. Alexandrov AV, Sloan MA, Wong LKS, Douville C, Razumovs AY, Koroshetz W, et al. Practice standards for transcranial Doppler ultrasound: Part I—test performance. J Neuroimaging. 2007;17(1):11-8.

  18. Wechsler LR, Ropper AH, Kistler P. Transcranial Doppler in cerebrovascular disease. Stroke.1986;17(5):905-12.




2020     |     www.medigraphic.com